Advanced Prostate Cancer: EMA Approves Abiraterone Combined With Hormone Therapy as First-line Treatment

News   Nov 22, 2017 | Original story from The Institute of Cancer Research

 
Advanced Prostate Cancer: EMA Approves Abiraterone Combined With Hormone Therapy as First-line Treatment

Credit: The Institute of Cancer Research

 
 
 

RELATED ARTICLES

Tailor-made Protein Fights Several Species of Bacteria

News

As resistance to existing antibiotics increases, new approaches to serious bacterial infections are needed. Now researchers have investigated one such alternative.

READ MORE

Anti-stress Compound Reduces Obesity and Diabetes

News

Scientists could prove that a stress protein found in muscle has a diabetes promoting effect. This finding could pave the way to a completely new treatment approach.

READ MORE

First Successful Gene Therapy Trial Reported for People with Hemophilia A

News

Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.

READ MORE

 

Comments | 1 ADD COMMENT

Leonard Adams | Dec 08, 2017

I had no idea about this. My urologist is very opposed to drugs that have not undergone through rigorous clinical trials, I have BPH and he prescribed me alpharise health. It has been a very effective cure for my bph symptoms.


Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE